You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Administrator
Staff member
-
cafead   Jun 26, 2023 at 10:02: AM
Administrator
Staff member
via Phase IIIa clinical trials reported more patients achieving target HbA1c with Novo Nordisk’s insulin compared to its once-daily counterparts.
article source